147 related articles for article (PubMed ID: 38319795)
1. Statin Therapy for Prevention of Anthracycline Cardiotoxicity - Another Defeat for Cardioprotection?
Divakaran S; Nohria A
NEJM Evid; 2022 Sep; 1(9):EVIDe2200166. PubMed ID: 38319795
[TBL] [Abstract][Full Text] [Related]
2. Statin Exposure and Risk of Heart Failure After Anthracycline- or Trastuzumab-Based Chemotherapy for Early Breast Cancer: A Propensity Score‒Matched Cohort Study.
Abdel-Qadir H; Bobrowski D; Zhou L; Austin PC; Calvillo-Argüelles O; Amir E; Lee DS; Thavendiranathan P
J Am Heart Assoc; 2021 Jan; 10(2):e018393. PubMed ID: 33401953
[TBL] [Abstract][Full Text] [Related]
3. Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
D'Amario D; Laborante R; Bianchini E; Galli M; Ciliberti G; Mennuni M; Patti G
Int J Cardiol; 2023 Nov; 391():131219. PubMed ID: 37527752
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase II
Kollárová-Brázdová P; Jirkovská A; Karabanovich G; Pokorná Z; Bavlovič Piskáčková H; Jirkovský E; Kubeš J; Lenčová-Popelová O; Mazurová Y; Adamcová M; Skalická V; Štěrbová-Kovaříková P; Roh J; Šimůnek T; Štěrba M
J Pharmacol Exp Ther; 2020 Jun; 373(3):402-415. PubMed ID: 32253261
[TBL] [Abstract][Full Text] [Related]
5. Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity: A Three Dimentional Echocardiography Study.
Mohamed AL; El-Abd AA; Mohamed HG; Noufal AM; Hennawy BS
Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102130. PubMed ID: 37858847
[TBL] [Abstract][Full Text] [Related]
6. Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Agarwal S; Guha A; Krishan S; Naqash AR; Addison D; Yang EH; Barac A; Asad ZUA
Am J Cardiol; 2023 Nov; 206():63-66. PubMed ID: 37683579
[No Abstract] [Full Text] [Related]
7. Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation.
Jirkovský E; Jirkovská A; Bavlovič-Piskáčková H; Skalická V; Pokorná Z; Karabanovich G; Kollárová-Brázdová P; Kubeš J; Lenčová-Popelová O; Mazurová Y; Adamcová M; Lyon AR; Roh J; Šimůnek T; Štěrbová-Kovaříková P; Štěrba M
Circ Heart Fail; 2021 Nov; 14(11):e008209. PubMed ID: 34551586
[TBL] [Abstract][Full Text] [Related]
8. Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy.
Dozic S; Howden EJ; Bell JR; Mellor KM; Delbridge LMD; Weeks KL
Cells; 2023 May; 12(9):. PubMed ID: 37174712
[TBL] [Abstract][Full Text] [Related]
9. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis.
Kalam K; Marwick TH
Eur J Cancer; 2013 Sep; 49(13):2900-9. PubMed ID: 23706982
[TBL] [Abstract][Full Text] [Related]
10. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.
Henriksen PA
Heart; 2018 Jun; 104(12):971-977. PubMed ID: 29217634
[TBL] [Abstract][Full Text] [Related]
11. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
Čiburienė E; Aidietienė S; Ščerbickaitė G; Sadauskienė E; Sudavičienė D; Baltruškevičienė E; Brasiūnienė B; Drobnienė M; Čelutkienė J
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138243
[No Abstract] [Full Text] [Related]
12. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study.
Seicean S; Seicean A; Plana JC; Budd GT; Marwick TH
J Am Coll Cardiol; 2012 Dec; 60(23):2384-90. PubMed ID: 23141499
[TBL] [Abstract][Full Text] [Related]
13. Statins for Attenuating Cardiotoxicity in Patients Receiving Anthracyclines: A Systematic Review and Meta-Analysis.
Titus A; Cheema HA; Shafiee A; Seighali N; Shahid A; Bhanushali KB; Kumar A; Khan SU; Khadke S; Thavendiranathan P; Hundley WG; Scherrer-Crosbie M; Nohria A; Neilan TG; Dani SS; Nasir K; Ganatra S
Curr Probl Cardiol; 2023 Oct; 48(10):101885. PubMed ID: 37336312
[TBL] [Abstract][Full Text] [Related]
14. Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers.
Henninger C; Fritz G
Cell Death Dis; 2017 Jan; 8(1):e2564. PubMed ID: 28102848
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes].
Tursunova NV; Klinnikova MG; Babenko OA; Lushnikova EL
Biomed Khim; 2020 Sep; 66(5):357-371. PubMed ID: 33140729
[TBL] [Abstract][Full Text] [Related]
16. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological strategies to reduce anthracycline-associated cardiotoxicity in cancer patients.
Stansfeld A; Radia U; Goggin C; Mahalingam P; Benson C; Napolitano A; Jones RL; Rosen SD; Karavasilis V
Expert Opin Pharmacother; 2022 Oct; 23(14):1641-1650. PubMed ID: 36102190
[TBL] [Abstract][Full Text] [Related]
18. Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis.
Obasi M; Abovich A; Vo JB; Gao Y; Papatheodorou SI; Nohria A; Asnani A; Partridge AH
Cancer Causes Control; 2021 Dec; 32(12):1395-1405. PubMed ID: 34406595
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
[TBL] [Abstract][Full Text] [Related]
20. Heart Failure in Relation to Anthracyclines and Other Chemotherapies.
Agunbiade TA; Zaghlol RY; Barac A
Methodist Debakey Cardiovasc J; 2019; 15(4):243-249. PubMed ID: 31988684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
